Neurogenic Inflammation

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-06-09
Clinical Trial Update: BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome [Phase 2]
Phase 2 clinical trial update for Botulinum Toxin Type A targeting peripheral neuropathic pain in carpal tunnel syndrome with neurogenic inf…